Zurich Insurance Group LTD Vertex Pharmaceuticals Inc Transaction History

Zurich Insurance Group LTD

$11.4 Billion
Q3 2024

A detailed history of Zurich Insurance Group LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Zurich Insurance Group LTD holds 53,262 shares of VRTX stock, worth $21.2 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

53,262

Previous 91,318 41.67%

Holding current value

$21.2 Million

Previous $42.8 Million 42.13%

% of portfolio

0.22%

Previous 0.38%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $17.5 Million - $19.2 Million	-38,056 Reduced 41.67%	53,262 $24.8 Million
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $35.9 Million - $44.3 Million	91,318 New	91,318 $42.8 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $17.3 Million - $20.7 Million	-50,359 Reduced 21.32%	185,815 $75.6 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $20.2 Million - $21.7 Million	-59,758 Reduced 20.19%	236,174 $82.1 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $93 Million - $104 Million	295,932 New	295,932 $104 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $7.81 Million - $10.5 Million	-46,850 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $258,321 - $290,737	1,554 Added 3.43%	46,850 $7.94 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $292,841 - $338,668	1,779 Added 4.09%	45,296 $8.31 Million
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $5.12 Million - $6.09 Million	-31,257 Reduced 41.8%	43,517 $8.01 Million
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $366,406 - $463,610	2,412 Added 3.33%	74,774 $12.4 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $5.63 Million - $6.47 Million	33,572 Added 86.55%	72,362 $13.9 Million
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $2.24 Million - $2.61 Million	-15,357 Reduced 28.36%	38,790 $6.59 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $2.52 Million - $2.95 Million	16,644 Added 44.38%	54,147 $8.83 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $631,899 - $715,996	4,603 Added 13.99%	37,503 $5.62 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $4.87 Million - $5.34 Million	32,900	32,900 $5 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $102B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurich Insurance Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Zurich Insurance Group LTD with notifications on news.

Account

Zurich Insurance Group LTD Vertex Pharmaceuticals Inc Transaction History